Daxor Corporation to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Daxor Corporation (DXR) will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City on September 10, 2026.
Rhea-AI Summary
Daxor Corporation (DXR) will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City on September 10, 2026. CEO and President Michael Feldschuh is scheduled to attend, and management plans to hold one-on-one and small group meetings with investors during the event. Interested investors are directed to their Lake Street contacts or to CORE IR for additional information and registration assistance.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Oak Ridge, TN, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in Lake Street's Tenth Annual Best Ideas Growth (BIG10) Conference in New York City, New York on Thursday, September 10th, 2026.
Management will host one-on-one and small group meetings with investors. For more information about the event or questions about registration, interested parties should reach out to their contacts at Lake Street.
Interested investors may also contact Bret Shapiro at CORE IR either by calling 1-516-222-2560 or emailing brets@coreir.com.
Sign up to receive news on Daxor’s innovative technology and investor announcements HERE.
About Daxor Corporation
Daxor Corporation (Nasdaq: DXR) is tackling healthcare's "multi-billion-dollar silent crisis", the inability to precisely measure blood volume. This often results in suboptimal care, prolonged hospital stays, and increased readmissions for many high-cost medical conditions like heart failure and those requiring ICU care. With 50 years of experience and innovation, Daxor is proud to manufacture and distribute its patented, FDA-cleared Blood Volume Analysis (BVA) diagnostic which offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. This empowers clinicians to make individualized treatment decisions that significantly improve patient outcomes and deliver substantial efficiencies in value-based healthcare. Daxor is ISO certified and operates a U.S.-based, 20,000-square-foot state-of-the-art manufacturing facility, positioning the company for accelerated market expansion.
Forward-Looking Statements
Certain statements in this release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation statements regarding the impact of hiring sales staff and expansion of our distribution channels. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risks associated with our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, FDA regulatory actions, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and additional other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Daxor does not assume any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact
Bret Shapiro
COO – Head of Capital Markets
COREIR
516-222-2560
brets@coreir.com|www.coreir.com
FAQ
How can investors get more information or register for Daxor’s meetings at the BIG10 Conference?
For information about the event or registration, interested parties are instructed to contact their representatives at Lake Street. Investors may also reach out to Bret Shapiro at CORE IR by calling 1-516-222-2560 or emailing brets@coreir.com.